Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Protein Science : a Publication of the Protein Society
|
August 18, 2025
Computational structure prediction of lanthipeptides with NMR data reveals underappreciated peptide flexibility
Claiborne W Tydings, Jens Meiler, Allison S Walker
Methods in Enzymology
|
May 23, 2026
Lanthipeptide structure prediction and design with Rosetta
Claiborne W Tydings, Rocco Moretti, Jens Meiler, et al.
Frontiers in Cell and Developmental Biology
|
March 18, 2024
Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins
Sarah J Harmych, Claiborne W Tydings, Jens Meiler, et al.
Protein Science : a Publication of the Protein Society
|
September 14, 2024
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics
Claiborne W Tydings, Bhuminder Singh, Adam W Smith, et al.
Cancer Letters
|
May 23, 2026
EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan
Sarah J Harmych, Neeraj Joshi, Hidenori Tanaka, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Protein Science : a Publication of the Protein Society
|
August 18, 2025
Computational structure prediction of lanthipeptides with NMR data reveals underappreciated peptide flexibility
Claiborne W Tydings, Jens Meiler, Allison S Walker
Methods in Enzymology
|
May 23, 2026
Lanthipeptide structure prediction and design with Rosetta
Claiborne W Tydings, Rocco Moretti, Jens Meiler, et al.
Frontiers in Cell and Developmental Biology
|
March 18, 2024
Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins
Sarah J Harmych, Claiborne W Tydings, Jens Meiler, et al.
Protein Science : a Publication of the Protein Society
|
September 14, 2024
Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics
Claiborne W Tydings, Bhuminder Singh, Adam W Smith, et al.
Cancer Letters
|
May 23, 2026
EGFR S442 ectodomain mutation confers cetuximab resistance that can be overcome by ERBB2 blockade with trastuzumab-deruxtecan
Sarah J Harmych, Neeraj Joshi, Hidenori Tanaka, et al.
Page
of 1